João Santos‐Antunes

Is it Possible to Change Phenotype Progression in Crohn's Disease in the Era of Immunomodulators? Predictive Factors of Phenotype Progression

Fernando Magro, Eduardo Rodrigues‐Pinto, Rosa Coelho et al. · The American Journal of Gastroenterology · 2014 · 95 citations

High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment

Fernando Magro, Eduardo Rodrigues‐Pinto, João Santos‐Antunes et al. · Journal of Crohn s and Colitis · 2013 · 92 citations

Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025

Mário Dinis‐Ribeiro, Diogo Libânio, Hugo Uchima et al. · Endoscopy · 2025 · 69 citations · Full text

Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis <scp>B</scp> vaccine in inflammatory bowel disease patients

Patrícia Andrade, João Santos‐Antunes, Susana Rodrigues et al. · Journal of Gastroenterology and Hepatology · 2015 · 63 citations

Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: Analysis of 25 patients matched with a control population

Cândida Abreu, Fernando Magro, João Santos‐Antunes et al. · Journal of Crohn s and Colitis · 2013 · 59 citations